With the future of medical innovation hanging in the balance, confusion surrounding the Sunshine Act has left those in the pharmaceutical industry in need of insight as they decide how best to collaborate with physicians. To address these concerns, the Pharmaceutical Compliance Monitor (PCM), a publication spotlighting regulatory and compliance news and developments for the pharmaceutical and biotechnology communities, sought the expertise of Thought Leader Select’s Paul Meade:
Pharma Compliance Monitor Solicits Industry Advice from Meade
With the future of medical innovation hanging in the balance, confusion surrounding the Sunshine Act has left those in the pharmaceutical industry in need of insight as they decide how best to collaborate with physicians. To address these concerns, the Pharmaceutical Compliance Monitor (PCM), a publication spotlighting regulatory and compliance news and developments for the pharmaceutical and biotechnology communities, sought the expertise of Thought Leader Select’s Paul Meade:
More Posts
Understanding Customer Beliefs and Preferences
By Paul Meade, Patient Engagement Lead In 2022, there are hundreds of thousands of healthcare companies in the United States alone. With this level of
Metrics That Determine Success for Field Medical Teams
By Mark Schoeman, General Manager When you’re in the medical field, one of the key things you need to be thinking about is what your
Technology is Getting Smarter
By Paul Meade, Patient Engagement Lead It has become apparent that in order for a healthcare organization to succeed, they need to be able to
Thought Leader Thursday: The Evolving KOL/MSL Engagement Model
Mark Schoeman, General Manager at Clear Point Health talks about the ways in which the KOL/MSL engagement model is changing.
Share:
Send Us A Message